Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Ovarian Neoplasms

  Free Subscription


Articles published in Am J Obstet Gynecol

Retrieve available abstracts of 33 articles:
HTML format



Single Articles


    October 2025
  1. KALRA A, Ganesan S, Sia JJY, Papalois KB, et al
    Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis.
    Am J Obstet Gynecol. 2025;233:276-291.
    PubMed     Abstract available


    September 2025
  2. MEYER LA, Ishizawa S, Toumazis I
    Use of a Natural History Model to Benchmark Progress in Managing Ovarian Cancer (Reply to Letter-to-the-Editor).
    Am J Obstet Gynecol. 2025 Sep 10:S0002-9378(25)00658.
    PubMed    


  3. MENG R
    Enhancing Clinical Translatability of Histology-Specific Ovarian Cancer Natural History Models (Letter-to-the-Editor).
    Am J Obstet Gynecol. 2025 Sep 10:S0002-9378(25)00659.
    PubMed    


    July 2025
  4. ISHIZAWA S, Eghbalizarch M, Nargund RS, Sarayi SMMJ, et al
    Development and Validation of a Histology-Specific Natural History Model of Ovarian Cancer.
    Am J Obstet Gynecol. 2025 Jul 4:S0002-9378(25)00459.
    PubMed     Abstract available


  5. BRODSKY AL, Flores Legarreta A, How JA, Vuttaradhi V, et al
    Survival outcomes comparing minimally invasive versus open cytoreductive surgery in recurrent adult-type granulosa cell tumors.
    Am J Obstet Gynecol. 2025;233:51.
    PubMed     Abstract available


    June 2025
  6. GOOTZEN TA, Steenbeek MP, van Gelder MMHJ, van Bommel MHD, et al
    Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study.
    Am J Obstet Gynecol. 2025 Jun 16:S0002-9378(25)00400.
    PubMed     Abstract available


    May 2025
  7. GUZEL HG, Balcik OY, Ilhan Y
    Reshaping the Landscape of Ovarian Cancer: Implications from the Surgery for Ovarian cancer FIGO 4 Study.
    Am J Obstet Gynecol. 2025 May 4:S0002-9378(25)00294.
    PubMed    


  8. JOCHUM F, Akladios C
    Primary vs interval cytoreductive surgery in stage IV ovarian cancer (SOFI-4).
    Am J Obstet Gynecol. 2025 May 3:S0002-9378(25)00295.
    PubMed    


    January 2025
  9. KARSTENSEN S, Jochumsen K, Hogdall C, Hogdall E, et al
    Ovarian sex cord-stromal cell tumors and the risk of sex hormone-sensitive cancers.
    Am J Obstet Gynecol. 2025 Jan 21:S0002-9378(25)00029.
    PubMed     Abstract available


    December 2024
  10. WU P, Zhou J, Zhang Y
    Incorporation of BRCA1 testing into prenatal carrier screening for hereditary breast and ovarian cancer prevention should take carrier rates into account.
    Am J Obstet Gynecol. 2024 Dec 11:S0002-9378(24)01181.
    PubMed    


    October 2024
  11. TANKOU J, Foley OW, Liu CY, Melamed A, et al
    Dermoid cyst management and outcomes: a review of over 1000 cases at a single institution.
    Am J Obstet Gynecol. 2024;231:442.
    PubMed     Abstract available


    August 2024
  12. ADJEI NN, Haas AM, Sun CC, Zhao H, et al
    Cost of ovarian cancer by the phase of care in the United States.
    Am J Obstet Gynecol. 2024 Aug 17:S0002-9378(24)00846.
    PubMed     Abstract available


  13. JOCHUM F, Dumas E, Gougis P, Hamy AS, et al
    Survival Outcomes of Primary versus Interval Cytoreductive Surgery for FIGO IV Ovarian Cancer (SOFI-4): a Nationwide Population-based Target Trial Emulation.
    Am J Obstet Gynecol. 2024 Aug 5:S0002-9378(24)00818.
    PubMed     Abstract available


    July 2024
  14. SUZUKI Y, Ferris JS, Chen L, Dioun S, et al
    Fertility-preserving Treatment for Stage IA Endometrial Cancer: A Systematic Review and Meta-Analysis.
    Am J Obstet Gynecol. 2024 Jul 18:S0002-9378(24)00761.
    PubMed     Abstract available


  15. MORO F, Pinto AP, Chiappa V, Testa AC, et al
    Prediction of non-resectability using the updated Predictive Index Value model assessed by imaging and surgery in tubo-ovarian cancer: a prospective multicenter ISAAC study.
    Am J Obstet Gynecol. 2024 Jul 3:S0002-9378(24)00740.
    PubMed     Abstract available


    June 2024
  16. WIJAYABAHU AT, Shiels M, Arend RC, Clarke MA, et al
    Uterine Cancer Incidence Trends and Five-Year Relative Survival by Race/Ethnicity and Histology Among Women Under 50 Years.
    Am J Obstet Gynecol. 2024 Jun 24:S0002-9378(24)00694.
    PubMed     Abstract available


    May 2024
  17. YI H, Zhang N, Huang J, Zheng Y, et al
    Association of Levonorgestrel-Releasing Intrauterine Device with Gynecologic and Breast Cancers: National Cohort Study in Sweden.
    Am J Obstet Gynecol. 2024 May 15:S0002-9378(24)00593.
    PubMed     Abstract available


    April 2024
  18. SUH-BURGMANN EJ, Hung YY, Schmittdiel JA
    Ovarian cancer risk among older patients with stable adnexal masses.
    Am J Obstet Gynecol. 2024 Apr 23:S0002-9378(24)00525.
    PubMed     Abstract available


  19. DIOUN SM, Perez LR, Prabhu M, Brewer JT, et al
    Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention.
    Am J Obstet Gynecol. 2024 Apr 13:S0002-9378(24)00520.
    PubMed     Abstract available


    March 2024
  20. LEE MW, Vallejo A, Furey KB, Woll SM, et al
    Racial and ethnic differences in early-death among gynecologic malignancy.
    Am J Obstet Gynecol. 2024 Mar 7:S0002-9378(24)00432.
    PubMed     Abstract available


  21. LU J, Guo Q, Zhang Y, Zhao S, et al
    A modified diffusion-weighted MRI-based model from the radiologist's perspective: improved performance in determining the surgical resectability for advanced high-grade serous ovarian cancer.
    Am J Obstet Gynecol. 2024 Mar 1:S0002-9378(24)00415.
    PubMed     Abstract available


    January 2024
  22. HOW JA, Legarreta AF, Handley KF, Fellman B, et al
    Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors.
    Am J Obstet Gynecol. 2024 Jan 6:S0002-9378(24)00009.
    PubMed     Abstract available


    September 2023
  23. JONSSON S, Jonsson H, Lundin E, Haggstrom C, et al
    Pelvic inflammatory disease and risk of epithelial ovarian cancer. A national population-based case-control study in Sweden.
    Am J Obstet Gynecol. 2023 Sep 29:S0002-9378(23)00723.
    PubMed     Abstract available


  24. LEE SS, Dinicu A, Arthurs L, Shileds D, et al
    Demographic reporting and language exclusion in gynecologic oncology clinical trials.
    Am J Obstet Gynecol. 2023 Sep 24:S0002-9378(23)00639.
    PubMed     Abstract available


    August 2023
  25. ZHOU J, Wu P, Zhang Y
    Patient-reported quality of life might depend on prophylactic or therapeutic surgery for women with higher genetic predisposition to breast/ovarian cancer.
    Am J Obstet Gynecol. 2023 Aug 31:S0002-9378(23)00597.
    PubMed    


  26. WEI X, Oxley S, Sideris M, Legood R, et al
    Patient-reported quality of life following prophylactic surgery for breast and ovarian cancer prevention: Response.
    Am J Obstet Gynecol. 2023 Aug 31:S0002-9378(23)00598.
    PubMed    


    June 2023
  27. BLUSTEIN P, Werner SR, Uppalapati P, Leung TM, et al
    Adherence to Risk-Reducing Salpingo-Oophorectomy Guidelines Among Gynecologic Oncologists Compared to General Gynecologists.
    Am J Obstet Gynecol. 2023 Jun 10:S0002-9378(23)00380.
    PubMed     Abstract available


    April 2023
  28. GOMEZ SL, Mcguire V, Collin LJ, Dempsey L, et al
    Disparities in ovarian cancer survival: does place matter?
    Am J Obstet Gynecol. 2023 Apr 26:S0002-9378(23)00263.
    PubMed     Abstract available


  29. WEI X, Oxley S, Sideris M, Kalra A, et al
    Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.
    Am J Obstet Gynecol. 2023 Apr 12:S0002-9378(23)00240.
    PubMed     Abstract available


  30. TERRA L, Beekman MJ, Engelhardt EG, Heemskerk-Gerritsen BAM, et al
    Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
    Am J Obstet Gynecol. 2023;228:440.
    PubMed     Abstract available


    March 2023
  31. MINALT N, Caldwell A, Yedlicka GM, Joseph S, et al
    Association of Intrauterine Device Use and Endometrial, Cervical, and Ovarian Cancer: an Expert Review.
    Am J Obstet Gynecol. 2023 Mar 29:S0002-9378(23)00224.
    PubMed     Abstract available


  32. FOSTER KI, Flores Legarreta A, Kamat R, Handley KF, et al
    Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.
    Am J Obstet Gynecol. 2023 Mar 10:S0002-9378(23)00148.
    PubMed     Abstract available


    November 2022
  33. CATHCART AM, Nezhat FR, Emerson J, Pejovic T, et al
    Adnexal masses during pregnancy: diagnosis, treatment and prognosis.
    Am J Obstet Gynecol. 2022 Nov 18:S0002-9378(22)02179.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.